How to Get Testosterone Enanthate in South Dakota

Prescription Requirements in South Dakota

Getting testosterone enanthate in South Dakota starts with a confirmed diagnosis of male hypogonadism. The Endocrine Society's 2018 clinical practice guideline defines hypogonadism as a total testosterone level below 300 ng/dL on two separate morning draws, combined with signs or symptoms such as fatigue, low libido, or reduced muscle mass.

Who Can Write the Prescription

South Dakota allows MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs) to prescribe Schedule III controlled substances, including testosterone enanthate. Each prescriber must hold an active DEA registration. NPs in South Dakota practice under a collaborative agreement with a physician for the first two years, after which they may prescribe independently. PAs prescribe under physician delegation.

What the Prescription Looks Like

A testosterone enanthate prescription in South Dakota must comply with DEA Schedule III regulations. This means the prescription can be phoned in, faxed, or transmitted electronically. Refills are permitted up to five times within six months of the original date. Most clinicians write for a 10 mL multi-dose vial of 200 mg/mL testosterone enanthate, dispensed as one vial per prescription cycle.

South Dakota Prescription Drug Monitoring Program

South Dakota operates the Prescription Drug Monitoring Program (PDMP) under SDCL 34-20E. Prescribers must check the PDMP before writing a new controlled substance prescription. This step adds no significant delay to the process but does require the prescriber to review the patient's dispensing history. The PDMP check is automatic for most electronic prescribing systems.

Lab Work Before Starting Testosterone Enanthate

The American Urological Association (AUA) 2018 guideline recommends a minimum laboratory panel before initiating testosterone therapy. Your provider will order baseline labs, and most South Dakota patients can complete these at any LabCorp or Quest Diagnostics draw site.

Required Baseline Labs

The standard pre-TRT panel includes total testosterone (drawn between 7 a.m. And 10 a.m.), free testosterone or sex hormone-binding globulin (SHBG), complete blood count (CBC) with hematocrit, comprehensive metabolic panel, and a lipid panel. For men over 40, the AUA guideline also recommends a baseline PSA. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) help distinguish primary from secondary hypogonadism.

Confirmatory Testing

A single low testosterone reading is insufficient. The Endocrine Society requires two morning samples on separate days, both below 300 ng/dL, before confirming a diagnosis. This two-sample requirement exists because testosterone levels fluctuate by 15 to 25% day to day due to circadian variation, illness, and stress.

Monitoring Once on Therapy

After starting testosterone enanthate, the Endocrine Society guideline recommends follow-up labs at 3 months, 6 months, and then annually. The key monitoring targets are trough testosterone (aiming for 400 to 700 ng/dL), hematocrit (must remain below 54%), and PSA in men over 40. The T-Trials, a series of seven coordinated trials published in The New England Journal of Medicine (N = 790), showed that testosterone treatment in men 65 and older raised hemoglobin by a mean of 1.0 g/dL, underscoring the importance of hematocrit surveillance.

Telehealth Access in South Dakota

South Dakota permits telehealth prescribing for testosterone enanthate. This opens access for residents in rural areas who may live hours from the nearest endocrinologist or men's health clinic.

How Telehealth TRT Works

A typical telehealth consultation follows a three-step process. First, the patient completes an intake questionnaire covering symptoms, medical history, and current medications. Second, the provider orders lab work at a local draw site. Third, after reviewing results, the provider conducts a synchronous video visit (required under South Dakota telehealth law SDCL 36-4-42) and, if appropriate, writes the prescription electronically to the patient's pharmacy of choice.

Ryan Haight Act Compliance

Because testosterone enanthate is a Schedule III substance, the Ryan Haight Online Pharmacy Consumer Protection Act requires at least one in-person or telehealth evaluation before a controlled substance can be prescribed. The DEA's 2023 telemedicine rule extension allows the initial evaluation to occur via video, provided the prescriber holds appropriate state and DEA licensure. South Dakota telehealth providers can therefore legally initiate testosterone enanthate without an in-person office visit.

Timeline From Consultation to Delivery

Most patients receive their testosterone enanthate within 5 to 10 business days of the initial consultation. The breakdown: 1 to 2 days for the intake, 2 to 3 days for lab results, 1 day for the video visit, and 2 to 4 days for pharmacy dispensing and shipping. Some telehealth platforms offer expedited processing that compresses this to 3 to 5 business days.

Pharmacy Access and 503A Compounding

South Dakota has both retail chain pharmacies and 503A compounding pharmacies that can fill testosterone enanthate prescriptions. Understanding the difference matters for cost and availability.

Retail Pharmacies

Commercially manufactured testosterone enanthate (brand name Delatestryl and generics) is available at major chains including CVS, Walgreens, and Lewis Drug locations across South Dakota. The FDA-approved labeling covers intramuscular injection for male hypogonadism at doses of 50 to 400 mg every 2 to 4 weeks. A 5 mL vial of generic testosterone enanthate 200 mg/mL typically costs $40 to $90 without insurance at South Dakota pharmacies.

503A Compounding Pharmacies

South Dakota licenses 503A compounding pharmacies that can prepare testosterone enanthate in custom concentrations or volumes based on a patient-specific prescription. Under FDA guidance on 503A compounding, these pharmacies must compound in response to a valid individual prescription and cannot produce batches for general distribution. South Dakota 503A pharmacies can ship directly to patients within the state, making them a practical option for rural residents.

Needles, Syringes, and Supplies

South Dakota does not require a prescription to purchase syringes. Patients can buy injection supplies over the counter at any pharmacy. Standard supplies for testosterone enanthate include 18-gauge drawing needles, 22- to 25-gauge injection needles (1 to 1.5 inches), and 3 mL Luer-lock syringes.

Insurance Coverage and Cost

Cost is a real barrier for some South Dakota patients. The coverage picture depends entirely on your insurance type.

Commercial Insurance

Most commercial plans in South Dakota cover testosterone enanthate for a confirmed diagnosis of male hypogonadism. Prior authorization is common. Documentation typically required includes two morning testosterone levels below 300 ng/dL, clinical symptoms documented in the chart, and evidence that reversible causes (such as opioid use or obstructive sleep apnea) have been evaluated. The Endocrine Society guideline provides the clinical framework that most insurers reference in their prior authorization criteria.

South Dakota Medicaid

South Dakota Medicaid does not cover testosterone enanthate for male hypogonadism. Patients relying on Medicaid will need to pay out of pocket or explore patient assistance programs. Generic testosterone enanthate remains one of the more affordable TRT options, with cash prices ranging from $40 to $90 per vial at South Dakota pharmacies.

Prior Authorization Documentation

A prior authorization request in South Dakota typically requires: the ICD-10 code for male hypogonadism (E29.1), two laboratory values confirming testosterone below 300 ng/dL per AUA diagnostic criteria, a list of symptoms, and a note explaining why alternative therapies (such as clomiphene citrate) are inappropriate or have been tried. Processing usually takes 3 to 5 business days. Appeals can extend this by 7 to 14 days.

Clinical Evidence Supporting Testosterone Enanthate

Testosterone enanthate has decades of clinical data. Several landmark studies inform its use.

The Testosterone Trials (T-Trials)

The T-Trials (NEJM, 2016) enrolled 790 men aged 65 and older with testosterone levels below 275 ng/dL. Over 12 months, testosterone gel improved sexual function (effect size 0.45, P<0.001), physical function, and mood compared to placebo. While the T-Trials used testosterone gel rather than enanthate, the pharmacologic endpoint (mid-normal testosterone levels) applies to both formulations.

Cardiovascular Safety Data

The TRAVERSE trial (NEJM, 2023; N = 5,246) was the first large randomized trial powered for cardiovascular outcomes. Men aged 45 to 80 with hypogonadism and preexisting or high risk for cardiovascular disease received testosterone or placebo for a mean of 33 months. The primary composite endpoint (cardiovascular death, nonfatal MI, nonfatal stroke) showed a hazard ratio of 0.99 (95% CI, 0.81 to 1.21), indicating no increased cardiovascular risk with testosterone treatment.

Bone Density Effects

A substudy of the T-Trials published in JAMA Internal Medicine (2017) demonstrated that testosterone treatment increased volumetric bone mineral density of the spine by 7.5% and estimated bone strength by 10.8% over 12 months. These findings are relevant for older hypogonadal men at risk of osteoporosis.

Hematocrit and Polycythemia Risk

Testosterone therapy raises hematocrit. A meta-analysis of 15 RCTs (Medicine, 2017) found that testosterone increased hematocrit by a weighted mean of 3.2%, with polycythemia (hematocrit above 54%) occurring in approximately 5% of treated patients. Dose reduction or temporary discontinuation resolves polycythemia in most cases.

South Dakota-Specific Regulations

A few state-level rules shape how testosterone enanthate is prescribed and dispensed in South Dakota.

Telehealth Licensing

Out-of-state providers prescribing to South Dakota patients must hold a South Dakota medical license or qualify under the Interstate Medical Licensure Compact, which South Dakota joined. This compact streamlines multi-state licensing for physicians, expanding the pool of telehealth prescribers available to South Dakota residents.

Controlled Substance Storage and Transport

Patients traveling within South Dakota should carry testosterone enanthate in its original pharmacy-labeled container. South Dakota law does not impose additional restrictions on personal-use transport of a properly prescribed Schedule III medication, but having the prescription label visible prevents complications during traffic stops or at airports (Sioux Falls Regional, Rapid City Regional).

Prescriber-Patient Relationship

Under SDCL 36-4-42, South Dakota defines a valid prescriber-patient relationship as one established through real-time interaction, either in person or via synchronous telehealth. Asynchronous (store-and-forward) evaluations alone do not satisfy this requirement for controlled substances.

Step-by-Step: Getting Started

For men ready to begin the process, here is the practical sequence. Order morning labs (total testosterone, free testosterone, CBC, CMP, lipid panel, PSA if over 40) at any South Dakota draw site. Repeat the testosterone draw on a second morning if the first result is below 300 ng/dL, per Endocrine Society protocol. Schedule either an in-person visit or a synchronous telehealth consultation. If diagnosed with hypogonadism, your provider writes the prescription electronically. Choose a retail or 503A pharmacy. Receive your testosterone enanthate and injection supplies. Complete your first injection under guidance (many providers offer virtual injection training). Return for follow-up labs at 3 months per the AUA monitoring recommendations.